Drugs

Hims & Hers launches Wegovy knockoff pill in U.S., Novo Nordisk vows to sue
Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly anticipated reformulation of the blockbuster medication.
New resource available for Manitoba physicians and pharmacists on prescribing ketamine
In response to the growing trend of ketamine being prescribed for off-label purposes, the College of Physicians and Surgeons of Manitoba has published a resource detailing key safety points for the drug for pharmacists and prescribers.

POP QUIZ: Musculoskeletal injury pain in children

Based on recent Canadian study results, which statement about treating moderate to severe acute pain following musculoskeletal injury in children is false?
Could this antiretroviral combat glioblastoma?

There may be a new way to slow the growth of glioblastoma with a medication already on the pharmacy shelf, new Canadian research finds.
Oral ivermectin or topical permethrin: Which is better for scabies treatment?

Study compares clinical cure rates with oral ivermectin versus topical permethrin 5% cream in scabies index cases and members of their households.
Sterile water or local anesthetic? ISMP Canada highlights another packaging look-alike

Two plastic ampoules that might not be twins—but could most definitely be sisters.
POP QUIZ: Preventing exercise-induced bronchoconstriction in children

Can you tell which statement about using salbutamol to prevent exercise-induced bronchoconstriction in children is false?
SGLT2 inhibitors vs. GLP-1 agonists for kidney outcomes in patients with type 2 diabetes

Study compares the effectiveness of SGLT2i and GLP-1RA treatment for acute and chronic kidney outcomes in patients with type 2 diabetes.
Spot the difference? ISMP Canada highlights two very similar vials

Always on the lookout for look-alikes, recent reports have highlighted a case of very similar packaging.
U.S. FDA says popular weight-loss drugs shouldn't carry suicide warnings

Labeling for other drugs known as GLP-1 receptor agonists approved to treat diabetes carried no such warnings, the agency noted.

Hims & Hers launches Wegovy knockoff pill in U.S., Novo Nordisk vows to sue

New resource available for Manitoba physicians and pharmacists on prescribing ketamine

POP QUIZ: Musculoskeletal injury pain in children

Could this antiretroviral combat glioblastoma?

Oral ivermectin or topical permethrin: Which is better for scabies treatment?

Sterile water or local anesthetic? ISMP Canada highlights another packaging look-alike

POP QUIZ: Preventing exercise-induced bronchoconstriction in children

SGLT2 inhibitors vs. GLP-1 agonists for kidney outcomes in patients with type 2 diabetes

Spot the difference? ISMP Canada highlights two very similar vials

U.S. FDA says popular weight-loss drugs shouldn't carry suicide warnings